Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

J Sargent

Showing results (71-80 of 514) with videos related to

Pageof 52
Sort By:
IEEE Transactions on Bio-Medical Engineering|May 1, 1991
Design and validation of the transparent oxygen sensor arrayB J Sargent, D A Gough
Lancet (London, England)|January 24, 2007
Adverse-event rates: journals versus databasesMichelle R Mahoney, Daniel J Sargent
Journal of Biopharmaceutical Statistics|December 7, 2006
Duffy-Santner confidence intervals for the two-stage three-outcome designAlfred F Furth, Daniel J Sargent
Journal of Thoracic Oncology : Official Publication of the International Association for the Study of Lung Cancer|June 29, 2010
Randomized phase II trials: time for a new era in clinical trial designSumithra J Mandrekar, Daniel J Sargent
Journal of the National Cancer Institute|November 4, 2010
Designing a randomized clinical trial to evaluate personalized medicine: a new approach based on risk predictionStuart G Baker, Daniel J Sargent
Nature Reviews. Clinical Oncology|October 8, 2014
Decade in review--clinical trials: shifting paradigms in cancer clinical trial designDaniel J Sargent, Edward L Korn
Chinese Clinical Oncology|January 8, 2017
Findings from the Adjuvant Colon Cancer End Points (ACCENT) Collaborative Group: the power of pooled individual patient data from multiple clinical trialsLindsay A Renfro, Daniel J Sargent
Journal of Medicinal Chemistry|August 1, 1972
Transformations in the morphine series. 5. Reaction of codeinone with dimethyloxosulfonium methylide. Structure and analgetic activity of the product and its reduced formL J Sargent, A E Jacobson
British Journal of Clinical Pharmacology|December 17, 2009
New central targets for the treatment of obesityBruce J Sargent, Nicholas A Moore
Current Opinion in Pharmacology|February 19, 2011
Targeting 5-HT receptors for the treatment of obesityBruce J Sargent, Alan J Henderson
Pageof 52

Showing results (71-80 of 514) with videos related to

Sort By:
Pageof 52
IEEE Transactions on Bio-Medical Engineering|May 1, 1991
Design and validation of the transparent oxygen sensor arrayB J Sargent, D A Gough
Lancet (London, England)|January 24, 2007
Adverse-event rates: journals versus databasesMichelle R Mahoney, Daniel J Sargent
Journal of Biopharmaceutical Statistics|December 7, 2006
Duffy-Santner confidence intervals for the two-stage three-outcome designAlfred F Furth, Daniel J Sargent
Journal of Thoracic Oncology : Official Publication of the International Association for the Study of Lung Cancer|June 29, 2010
Randomized phase II trials: time for a new era in clinical trial designSumithra J Mandrekar, Daniel J Sargent
Journal of the National Cancer Institute|November 4, 2010
Designing a randomized clinical trial to evaluate personalized medicine: a new approach based on risk predictionStuart G Baker, Daniel J Sargent
Nature Reviews. Clinical Oncology|October 8, 2014
Decade in review--clinical trials: shifting paradigms in cancer clinical trial designDaniel J Sargent, Edward L Korn
Chinese Clinical Oncology|January 8, 2017
Findings from the Adjuvant Colon Cancer End Points (ACCENT) Collaborative Group: the power of pooled individual patient data from multiple clinical trialsLindsay A Renfro, Daniel J Sargent
Journal of Medicinal Chemistry|August 1, 1972
Transformations in the morphine series. 5. Reaction of codeinone with dimethyloxosulfonium methylide. Structure and analgetic activity of the product and its reduced formL J Sargent, A E Jacobson
British Journal of Clinical Pharmacology|December 17, 2009
New central targets for the treatment of obesityBruce J Sargent, Nicholas A Moore
Current Opinion in Pharmacology|February 19, 2011
Targeting 5-HT receptors for the treatment of obesityBruce J Sargent, Alan J Henderson
Pageof 52